SciELO - Scientific Electronic Library Online

 
vol.61 número2Seguridad de la sedación con propofol administrado por gastroenterólogos en endoscopia digestivaLiving donor bone bank: Costa Rican experience índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Acta Médica Costarricense

versión On-line ISSN 0001-6002versión impresa ISSN 0001-6012

Resumen

RIVERA-CHAVARRIA, Ana  y  ESPINOZA-AGUIRRE, Azálea. Thalidomide in Costa Rica: uses, regulatory and ethical context. Acta méd. costarric [online]. 2019, vol.61, n.2, pp.73-76. ISSN 0001-6002.

In recent decades, thalidomide´s anti-inflammatory, anti-angiogenic and immunoregulatory properties have led as an alternative or second-choice therapy for various pathologies. It is currently included in the Official List of Medicines and Regulations of the Costa Rican Social Security (LOM). However, thalidomide´s resurgence and its analogues, reproductive behavior changes, assisted reproduction technology, biomedical research and medical judicialization, indicates that a review of the current indications and safety measures are necessary to prevent the most serious adverse effect: teratogenesis. In this research, we aim to summarize thalidomide´s current uses, regulatory and ethical context in Costa Rica.

Palabras clave : Thalidomide; IMiDS; ethical issues; regulation.

        · resumen en Español     · texto en Español     · Español ( pdf )